Spine Surgeon Led

SynerFuse® e-Fusion™ (also known as e-TLIF™) is an investigational procedure that pairs spinal fusion with direct nerve stimulation to provide Ultra Low Energy™ (ULE™) Technology. It is designed to address chronic low back and leg pain in spinal fusion patients.

Too many people are living with outcomes that are not acceptable to them.

619 million

people worldwide live with low back pain

World Health Organization

over 450,000

spinal fusions performed each year in the United States

AHRQ HCUP

nearly 80,000

U.S. deaths involving opioids in 2023

Centers for Disease Control and Prevention

$134.5 billion

spent on low back and neck pain in the United States

Dieleman et al., JAMA, 2020

An unacceptable number of people rely on opioids after a successful spinal fusion.

Ong et al., Am J Manag Care, 2018

These figures describe the disease state and are provided for context, not a product claim.

One procedure – Integrated technologies

During lumbar fusion surgery, the surgeon also places a lead designed to deliver direct nerve stimulation at the same spinal level, through the same incision. Fusion and Ultra Low Energy™ (ULE™) Technology happen in one operation instead of in separate surgeries.

See how the NeuroFuse® System works

Spinal fusion plus ULE™ equals SynerFuse: the e-Fusion procedure, delivering ULE™ (Ultra Low Energy™) Technology

Built around the patient and the surgeon

Patient-focused and integrated

Stimulation is placed during the fusion surgery the patient is already having. The procedure is designed to improve the patient experience by integrating Ultra Low Energy™ (ULE™) Technology with spinal fusion.

Surgeon-led

Neuropathic pain is designed to be addressed at the same spinal level as the surgery, through a single incision. The system is designed for spine surgeons.

ULE™ technology

Ultra Low Energy™ Technology is designed to work alongside the fusion hardware the surgeon already prefers.

Clinical research

SynerFuse® completed a 15-patient feasibility study of the e-Fusion™ procedure with the University of Minnesota, South Bend Orthopaedics and RQM+. A 150 patient clinical trial is being prepared with the Big Ten Neurosurgery Consortium, a network of 17 member institutions serving patients across the United States.

Feasibility study sites

  • Minneapolis, Minnesota
  • South Bend, Indiana

SynerFuse® Powered by QuantumStim™

Every company within QuantumStim™ plays a unique role in advancing medical technology.

QuantumStim™

Parent company advancing medical technology from innovation to commercialization.

Med-Ally Medical™

Engineering, product development, regulatory support and advanced manufacturing.

Omni Surgery Center

A future physician-focused care environment designed to bring innovative therapies to patients.

OmniPNS™

Patient first, physician-led, transformed lives.

Latest news

Talk with SynerFuse

Questions about the e-Fusion™ procedure, research collaboration or investing? The team in Eden Prairie, Minnesota, will connect you with the right person.